NextCure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. 

CEO
Michael S. Richman
CEOMichael S. Richman
Employees
40
Employees40
Headquarters
Beltsville, Maryland
HeadquartersBeltsville, Maryland
Founded
2015
Founded2015
Employees
40
Employees40

NXTC Key Statistics

Market cap
34.43M
Market cap34.43M
Price-Earnings ratio
-0.41
Price-Earnings ratio-0.41
Dividend yield
Dividend yield
Average volume
88.01K
Average volume88.01K
High today
$9.68
High today$9.68
Low today
$9.13
Low today$9.13
Open price
$9.13
Open price$9.13
Volume
11.46K
Volume11.46K
52 Week high
$15.74
52 Week high$15.74
52 Week low
$4.09
52 Week low$4.09

Stock Snapshot

The current NextCure(NXTC) stock price is $9.67, with a market capitalization of 34.43M. The stock trades at a price-to-earnings (P/E) ratio of -0.41.

As of 2026-05-05, NextCure(NXTC) stock has fluctuated between $9.13 and $9.68. The current price stands at $9.67, placing the stock +5.9% above today's low and -0.1% off the high.

NextCure(NXTC) shares are trading with a volume of 11.46K, against a daily average of 88.01K.

During the past year, NextCure(NXTC) stock moved between $4.09 at its lowest and $15.74 at its peak.

During the past year, NextCure(NXTC) stock moved between $4.09 at its lowest and $15.74 at its peak.

NXTC News

TipRanks 1d
NextCure initiates dose optimization portion of SIM0505 study

NextCure (NXTC) announced initiation of the dose optimization portion of the Phase 1 study of SIM0505, focusing on patients with platinum-resistant ovarian canc...

People also own

Based on the portfolios of people who own NXTC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.